Health Sciences Group Launches New Shugr Website
23 5월 2006 - 9:30PM
Business Wire
Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative
nutraceutical products and functional food ingredients derived from
natural sources, today announced the launch of a new website for
its Swiss Diet Shugr(TM) The new website -- located at
www.shugr.com -- offers visitors comprehensive information on
Shugr(TM) and its ingredients as well as other information offering
tips for healthy eating and living. The website will be updated
regularly to reflect the latest list of Shugr(TM) retailers as well
as news and information on specials and new product offerings.
Shugr(TM), a zero-calorie, low glycemic sweetener that tastes and
measures like table sugar, is made from sugars that occur naturally
in such good-tasting, healthy foods such as fruits, vegetables,
corn and dairy products. Erythritol is a naturally-occurring sugar
commonly found in melon, grapes, mushrooms and soy. Tagatose comes
from dairy products, but does not affect people who are lactose
intolerant. Tagatose also provides an added health benefit --
prebiotic fiber that promotes intestinal health, much the way
yogurt does. Maltodextrin is derived from corn sugar, which is
non-GMO and gluten-free. A trace amount of sucralose is added to
give Shugr its "high note." All of these ingredients carry a GRAS
(Generally Recognized As Safe) designation for food safety from the
US Food & Drug Administration. About Health Sciences Group,
Inc. Health Sciences Group identifies, develops and commercializes
innovative nutraceutical products derived from natural sources to
provide consumers and medical professionals with preventative
healthcare alternatives. The company markets its own line of
proprietary products based on novel technologies with
clinically-supported, GRAS-certified ingredients. For more
information, visit www.HealthSciencesGroup.com, www.Sequesterol.com
and www.Shugr.com. This release contains forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934 that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events. Although the Company believes that the
expectations reflected in the forward-looking statements and the
assumptions upon which they are based are reasonable, it can give
no assurance that such expectations and assumptions will prove to
have been correct. The reader is cautioned not to put undue
reliance on these forward-looking statements, as these statements
are subject to numerous factors and uncertainties, including
without limitation, the independent authority of the special
committee to act on the matters discussed, the successful
negotiation of the potential acquisition and disposal of
transactions described above, successful implementation of the
company's business strategy and competition, any of which may cause
actual results to differ materially from those described in the
statements. In addition, other factors that could cause actual
results to differ materially are discussed in the Company's most
recent Form 10-QSB and Form 10-KSB filings with the Securities and
Exchange Commission.
Health Sciences (CE) (USOTC:HESG)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Health Sciences (CE) (USOTC:HESG)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Health Sciences Group Inc (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Health Sciences Group, Inc. News Articles